1-7 of 7
Ranjani Rajapaksa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treating B Cell Lymphomas with Anti CD81 Antibodies

Felipe Vences-Catalan, PhD, Chiung-Chi Kuo, MsC, Ranjani Rajapaksa, PhD, Caroline Duault, PhD, Ronald Levy, MD, Shoshana Levy, PhD
Journal: Blood
Blood (2016) 128 (22): 4180.
https://doi.org/10.1182/blood.V128.22.4180.4180
Published: 2016
Journal Articles

The Tetraspanin CD81 Facilitates Tumor Metastasis By Modulating Immune Suppression

Felipe Vences Catalan, PhD, Ranjani Rajapaksa, PhD, Minu K. Srivastava, PhD, Aurelien Marabelle, MD PhD, Shoshana Levy, PhD
Journal: Blood
Blood (2014) 124 (21): 4136.
https://doi.org/10.1182/blood.V124.21.4136.4136
Published: 2014
Journal Articles

Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites

Aurelien Marabelle, M.D., MSc, Holbrook E Kohrt, MD, Joshua Brody, MD, James Anthony Torchia, Gang Zhou, Richard Luong, BVSc, DACVP, Ranjani Rajapaksa, PhD, Victor Tse, M.D., PhD, Ronald Levy, MD
Journal: Blood
Blood (2011) 118 (21): LBA-2.
https://doi.org/10.1182/blood.V118.21.LBA-2.LBA-2
Published: 2011
Journal Articles

A CpG-loaded tumor cell vaccine induces antitumor CD4 + T cells that are effective in adoptive therapy for large and established tumors

Matthew J. Goldstein, Bindu Varghese, Joshua D. Brody, Ranjani Rajapaksa, Holbrook Kohrt, Debra K. Czerwinski, Shoshana Levy, Ronald Levy
Journal: Blood
Blood (2011) 117 (1): 118–127.
https://doi.org/10.1182/blood-2010-06-288456
Published: 2011
Includes: Supplemental data
Journal Articles

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Matthew J Goldstein, Bindu Varghese, PhD, Ranjani Rajapaksa, PhD, Joshua Brody, MD, Shoshana Levy, PhD, Ronald Levy, MD
Journal: Blood
Blood (2009) 114 (22): 929.
https://doi.org/10.1182/blood.V114.22.929.929
Published: 2009
Journal Articles

HGAL is a novel interleukin-4–inducible gene that strongly predicts survival in diffuse large B-cell lymphoma

Clinical Trials & Observations
Izidore S. Lossos, Ash A. Alizadeh, Ranjani Rajapaksa, Robert Tibshirani, Ronald Levy
Journal: Blood
Blood (2003) 101 (2): 433–440.
https://doi.org/10.1182/blood-2002-06-1931
Published: 2003
Journal Articles

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

Clinical Trials & Observations
John M. Timmerman, Debra K. Czerwinski, Thomas A. Davis, Frank J. Hsu, Claudia Benike, Zheng Mei Hao, Behnaz Taidi, Ranjani Rajapaksa, Clemens B. Caspar, Craig Y. Okada, Adrienne van Beckhoven, Tina Marie Liles, Edgar G. Engleman, Ronald Levy
Journal: Blood
Blood (2002) 99 (5): 1517–1526.
https://doi.org/10.1182/blood.V99.5.1517
Published: 2002